Provention Bio Inc. (PRVB) Tops Q4 EPS by 4c
Tweet
Share
E-mail
Get Alerts PRVB Hot Sheet
Join SI Premium – FREE
Provention Bio Inc. (NASDAQ: PRVB) reported Q4 EPS of ($0.41), $0.04 better than the analyst estimate of ($0.45).
For earnings history and earnings-related data on Provention Bio Inc. (PRVB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Tvardi Therapeutics (TVRD) Tops Q2 EPS by 1c
- Star Equity Holdings (STRR) Misses Q2 EPS by 8c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
